Table 2.
Van der Waals interactions in the modelled complexes of MBP87–96 peptide and mutant analogues with H2 I-As
Peptide residue | MHC residue | MBP87–96 | [A91,A96]MBP87–96 | [R91,A96]MBP87–96 |
---|---|---|---|---|
V87 | Y9(A)1 | + | − | + |
V87 | F54(A) | + | + | + |
V87 | H81(B)2 | + | − | − |
V87 | N82(B) | + | − | + |
H88 | E74(B) | + | + | + |
H88 | T77(B) | + | + | + |
H88 | V78(B) | + | + | + |
F89 | Y9(A) | + | − | + |
F89 | F54(A) | + | + | + |
F89 | G58(A) | + | + | + |
F89 | V78(B) | − | + | − |
F90 | F11(B) | + | + | + |
F90 | G13(B) | + | + | + |
F90 | E14(B) | + | + | + |
F90 | C15(B) | + | + | + |
F90 | V78(B) | + | + | − |
F90 | C79(B) | − | + | − |
K91 | Q70(B) | + | n/a3 | n/a |
R91/A91 | F11(B) | n/a | + | + |
R91 | Y67(B) | n/a | n/a | + |
N92 | T65(A) | + | + | + |
N92 | F11(B) | + | + | + |
I93 | T65(A) | + | + | + |
I93 | Y61(B) | + | + | + |
I93 | Y67(B) | + | + | + |
V94 | T65(A) | + | − | + |
V94 | Y61(B) | − | + | − |
V94 | Y68(A) | + | + | + |
T95 | D57(B) | + | + | + |
T95 | T69(A) | − | + | + |
T95 | Y61(B) | − | + | − |
P96 | Y60(B) | + | n/a | n/a |
α-chain,
β-chain,
not applicable.
MHC, major histocompatibility complex.